CREDIT SUISSE AG/ - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 59 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$1,114,0000.0%900,0000.0%0.00%0.0%
Q4 2021$1,114,000
+47.5%
900,000
+50.0%
0.00%
Q3 2021$755,000
-5.3%
600,0000.0%0.00%
Q2 2021$797,000
-1.2%
600,0000.0%0.00%
Q1 2021$807,000
+94.9%
600,000
+100.0%
0.00%
Q4 2020$414,000
+0.2%
300,0000.0%0.00%
Q3 2020$413,000
-63.0%
300,000
-55.4%
0.00%
-100.0%
Q2 2020$1,117,000
+86.8%
672,000
+43.9%
0.00%0.0%
Q1 2020$598,000
-16.4%
467,0000.0%0.00%0.0%
Q4 2019$715,000
-55.6%
467,000
-60.3%
0.00%0.0%
Q3 2019$1,609,000
-26.8%
1,175,000
-29.9%
0.00%
-50.0%
Q2 2019$2,198,000
+14.5%
1,675,000
+18.0%
0.00%0.0%
Q1 2019$1,919,000
+436.0%
1,420,000
+373.3%
0.00%
Q4 2018$358,000
-73.7%
300,000
-62.5%
0.00%
-100.0%
Q3 2018$1,363,000
-46.0%
800,000
-54.3%
0.00%
-50.0%
Q2 2018$2,526,0001,750,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aequim Alternative Investments LP 24,000,000$30,877,0005.11%
Alken Asset Management Ltd 360,000$457,0001.90%
III Capital Management 3,500,000$4,481,0001.64%
SHENKMAN CAPITAL MANAGEMENT INC 3,920,000$5,113,0000.76%
CSS LLC/IL 6,842,000$8,745,0000.69%
DeepCurrents Investment Group LLC 10,408,000$13,373,0000.65%
SSI INVESTMENT MANAGEMENT LLC 4,334,000$5,554,0000.49%
WOLVERINE ASSET MANAGEMENT LLC 18,250,000$23,476,0000.34%
MACKAY SHIELDS LLC 24,612,000$31,641,0000.29%
Nicholas Investment Partners, LP 1,115,000$1,429,0000.28%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders